HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dimo Dietrich Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

1/2024Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.
1/2021CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma.
1/2020LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma.
1/2019Cell-Free SHOX2 DNA Methylation in Blood as a Molecular Staging Parameter for Risk Stratification in Renal Cell Carcinoma Patients: A Prospective Observational Cohort Study.
8/2017Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma.
1/2017Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma.
12/2016Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.
10/2016The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.
4/2015Epigenetic biomarkers in the blood of patients with urological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dimo Dietrich Research Topics

Disease

55Neoplasms (Cancer)
04/2024 - 10/2008
22Squamous Cell Carcinoma of Head and Neck
01/2023 - 11/2016
18Prostatic Neoplasms (Prostate Cancer)
01/2024 - 05/2010
12Melanoma (Melanoma, Malignant)
01/2024 - 12/2018
9Renal Cell Carcinoma (Grawitz Tumor)
01/2024 - 04/2015
8Carcinoma (Carcinomatosis)
01/2023 - 11/2010
8Lung Neoplasms (Lung Cancer)
01/2015 - 09/2009
7Breast Neoplasms (Breast Cancer)
12/2021 - 10/2008
6Disease Progression
01/2021 - 10/2008
5Neoplasm Metastasis (Metastasis)
01/2022 - 06/2010
4Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 12/2018
4Pleural Effusion (Pleural Effusions)
01/2018 - 01/2013
4Ascites
01/2018 - 01/2014
4Hypoxia (Hypoxemia)
02/2017 - 01/2014
3Carcinogenesis
01/2022 - 04/2014
3Adenocarcinoma
01/2021 - 02/2015
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2017
2Uveal melanoma
01/2023 - 01/2022
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021 - 08/2019
2Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2017 - 01/2017
2Adenoma (Adenomas)
01/2016 - 12/2015
2Margins of Excision
02/2015 - 03/2013
1Multiple Sclerosis
11/2023
1Residual Neoplasm
01/2023
1Infections
01/2022
1Lymphatic Metastasis
01/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2021
1Triple Negative Breast Neoplasms
10/2021
1Papillary Thyroid Cancer
01/2020
1Lymphoma (Lymphomas)
01/2020
1Glioma (Gliomas)
02/2018
1Papillomavirus Infections
01/2018

Drug/Important Bio-Agent (IBA)

52Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2009
27Messenger RNA (mRNA)IBA
11/2023 - 10/2008
18DNA (Deoxyribonucleic Acid)IBA
01/2023 - 10/2008
16Proteins (Proteins, Gene)FDA Link
11/2023 - 04/2014
12Immune Checkpoint InhibitorsIBA
01/2024 - 02/2017
9Cell-Free Nucleic AcidsIBA
01/2024 - 10/2016
6InterferonsIBA
01/2023 - 10/2019
6Long Noncoding RNAIBA
01/2021 - 04/2015
5N-acetyltalosaminuronic acid (NAT)IBA
01/2020 - 03/2011
5hydrogen sulfite (bisulfite)IBA
01/2017 - 06/2010
5Hormones (Hormone)IBA
12/2016 - 10/2008
4RNA (Ribonucleic Acid)IBA
11/2023 - 08/2014
4DecitabineFDA Link
06/2023 - 11/2022
4SeptinsIBA
01/2023 - 07/2017
3B7-H1 AntigenIBA
01/2023 - 04/2016
3LigandsIBA
10/2020 - 01/2017
3MyoglobinIBA
12/2016 - 01/2014
3SteroidsIBA
10/2014 - 10/2008
2enfortumab vedotinIBA
04/2024 - 10/2022
2Immunoconjugates (Immunoconjugate)IBA
04/2024 - 10/2022
2Prostate-Specific Antigen (Semenogelase)IBA
01/2024 - 03/2013
2MethyltransferasesIBA
01/2023 - 01/2023
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2022 - 02/2020
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
12/2021 - 03/2021
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
12/2021 - 03/2021
2Tyrosine Kinase InhibitorsIBA
12/2021 - 03/2021
2Monoclonal AntibodiesIBA
03/2021 - 04/2016
2Tumor Biomarkers (Tumor Markers)IBA
01/2020 - 11/2010
2Programmed Cell Death 1 ReceptorIBA
08/2017 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2017 - 01/2017
2Formaldehyde (Formol)FDA Link
11/2016 - 06/2012
2ParaffinIBA
11/2016 - 06/2012
2CytokinesIBA
01/2016 - 04/2014
2Androgen Receptors (Androgen Receptor)IBA
01/2016 - 10/2014
2MicroRNAs (MicroRNA)IBA
04/2015 - 08/2014
2Nucleic AcidsIBA
08/2014 - 08/2014
2AnthracyclinesIBA
06/2010 - 01/2009
2Estrogen ReceptorsIBA
06/2010 - 01/2009
1Circulating Tumor DNAIBA
01/2024
1CTLA-4 AntigenIBA
01/2023
1Keratins (Keratin)IBA
01/2022
1AZD4547IBA
12/2021
1Cyclin D1IBA
12/2021
1PD 173074IBA
12/2021
1Cisplatin (Platino)FDA LinkGeneric
11/2021
1Ion Channels (Ion Channel)IBA
11/2021
1IpilimumabIBA
06/2021
1AntibodiesIBA
11/2020
1src-Family KinasesIBA
10/2020
1Tyrosine (L-Tyrosine)FDA Link
10/2020
1EnzymesIBA
10/2020
1Histones (Histone)IBA
10/2020
1Histone MethyltransferasesIBA
10/2020
1Azacitidine (5 Azacytidine)FDA Link
09/2020
1Galectins (Galectin)IBA
11/2019
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
10/2019
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
02/2018
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
01/2018
15'-Nucleotidase (5' Nucleotidase)IBA
01/2018
1oligomycin sensitivity-conferring protein (complex V)IBA
08/2017
1Adenosine Triphosphate (ATP)IBA
08/2017
1Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA
08/2017

Therapy/Procedure

19Therapeutics
11/2022 - 06/2010
16Immunotherapy
01/2024 - 06/2017
9Prostatectomy (Retropubic Prostatectomy)
01/2017 - 05/2010
3Drug Therapy (Chemotherapy)
11/2021 - 01/2009
2Precision Medicine
11/2021 - 04/2015
1Palliative Care (Palliative Therapy)
01/2020